Altimmune (ALT) EBT Margin (2009 - 2025)
Altimmune (ALT) recorded EBT Margin of -105223.08% in Q4 2025, up 358376.92 percentage points from -463600.00% a year earlier and up 275056.92 percentage points from the prior quarter.
Altimmune (ALT) EBT Margin (2009 - 2025) Analysis & Trends
For FY2025, Altimmune reported EBT Margin of -216521.95%, up 258773.05 percentage points from FY2024.
- Annual EBT Margin has a five-year change of -215856.57 percentage points (FY2020 to FY2025).
- Across earlier years, EBT Margin came in at -475295.00% in FY2024 (-454532.79 pp), -20762.21% in FY2023 (+104105.44 pp), -124867.65% in FY2022 (-122666.06 pp) and -2201.59% in FY2021 (-1536.21 pp).
- The Q4 2025 figure is the highest quarterly EBT Margin since Q4 2023.
- On a year-over-year basis, EBT Margin has increased for four consecutive quarters, with an average year-over-year change of -109633.63 percentage points over the last eight quarters.
- Peak year-over-year performance for EBT Margin in the last five years was a gain of 1179939.78 percentage points in Q3 2023, against a drop of 1164441.14 percentage points in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at -380280.00% (Q3 2025), -442920.00% (Q2 2025) and -405120.00% (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 26.27% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 45.21% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 20.41% |
| 10 | Altimmune | 377.28 Mn | -764.94 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -105,223.08% |
| Sep 30, 2025 | -380,280.00% |
| Jun 30, 2025 | -442,920.00% |
| Mar 31, 2025 | -405,120.00% |
| Dec 31, 2024 | -463,600.00% |
| Sep 30, 2024 | -456,900.00% |
| Jun 30, 2024 | -492,800.00% |
| Mar 31, 2024 | -487,880.00% |
| Dec 31, 2023 | -85,516.22% |
| Sep 30, 2023 | -5,710.22% |
| Jun 30, 2023 | -269,566.67% |
| Mar 31, 2023 | -95,680.95% |
| Dec 31, 2022 | -83,307.69% |
| Sep 30, 2022 | -1,185,650.00% |
| Jun 30, 2022 | -251,650.00% |
| Mar 31, 2022 | -61,062.50% |
| Dec 31, 2021 | -728.99% |
| Sep 30, 2021 | -21,208.86% |
| Jun 30, 2021 | -18,121.68% |
| Mar 31, 2021 | -1,773.76% |
Altimmune EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=ALT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "ALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=ALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();